About Intelligent and Health Care
Artificial intelligence (AI) is steadily being used to healthcare, as it becomes increasingly prevalent in modern industry and everyday life. Artificial intelligence in healthcare has the potential to help healthcare providers in a variety of ways, including patient care and administrative tasks. Although most AI and healthcare technologies have a close connection to the healthcare industry, the strategies they support can be rather different. Even though some publications on artificial intelligence in healthcare claim potential AI can perform almost as well as or better than humans at specific processes, which including disease diagnosis, it will be a long time before AI in healthcare replaces people for a wide range of medical operations.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
CAGR | 38.5% |
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Intelligent and Health Care market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
IBM Watson Health (United States), Microsoft Corporation (United States), Intel Corporation (United States), General Electric Company (United States), Nvidia Corporation (United States), Verint Systems (United States), Enlitic Inc. (United States), DeepMind (United States), Oncora Medical (United States) and CloudMedX Health (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Babylon Health (United Kingdom), Corti (Denmark) and General Vision, Inc. (United States).
Segmentation Overview
AMA Research has segmented the market of Global Intelligent and Health Care market by Type (Machine Learning, Natural Language Processing, Rule-Based Expert Systems, Physical Robots and Robotic Process Automation), Application (Drug Development, Patient Experience, Robotic Surgeries, Virtual Nursing Assistants, Support In Clinical Decisions, Diagnosis And Reporting, Process Automation, Managing And Mining Medical Data and Other) and Region.
On the basis of geography, the market of Intelligent and Health Care has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Component, the sub-segment i.e. Hardware will boost the Intelligent and Health Care market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals & Diagnostic Centres will boost the Intelligent and Health Care market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Advancements In Big Data Analytics and Integration Of Advance Technology AI & ML
Market Growth Drivers:
Rapidly Digitization In Healthcare Sector and Surge In Personalized Treatments Fuels The Market Growth
Challenges:
Lack Of Investment In Healthcare Infrastructure
Restraints:
High Cost Associated With Technology
Opportunities:
Growing Safety Concerns About The Patient Data and Government Favorable Incentives To Development Of Healthcare
Market Leaders and their expansionary development strategies
In January 2023, Terumo and Siemens Healthineers India worked together to strengthen heart care in India. As a result of this collaboration, more people will be able to access better cardiac care.
Key Target Audience
Intelligent and Health Care Provider, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.